Purification and Characterization of Gigantoxin-4, a New Actinoporin from the Sea Anemone Stichodactyla Gigantea by Hu, Bo et al.





I In nt te er rn na at ti io on na al l   J Jo ou ur rn na al l   o of f   B Bi io ol lo og gi ic ca al l   S Sc ci ie en nc ce es s   
2011; 7(6):729-739 
Research Paper 
Purification and Characterization of Gigantoxin-4, a New Actinoporin from 
the Sea Anemone Stichodactyla Gigantea   
Bo Hu*, Wei Guo*, Liang-hua Wang*, Jian-guang Wang, Xiao-yu Liu
, Bing-hua Jiao
 
Department of Biochemistry and Molecular Biology, Second Military Medical University, Shanghai 200433, China 
* These authors made equal contributions to this work.  
  Corresponding  author:  Department  of  Biochemistry  and  Molecular  Biology,  Second  Military  Medical  University, 
Shanghai  200433,  China.  Tel:  86-21-81870965;  Fax:  86-21-65334344.  E-mail:  liuxiaoyu8888@msn.com  (Xiao-yu  Liu), 
jiaobh@live.cn (Bing-hua Jiao). 
© Ivyspring International Publisher. This is an open-access article distributed under the terms of the Creative Commons License (http://creativecommons.org/ 
licenses/by-nc-nd/3.0/). Reproduction is permitted for personal, noncommercial use, provided that the article is in whole, unmodified, and properly cited. 
Received: 2011.04.04; Accepted: 2011.05.30; Published: 2011.06.07 
Abstract 
A new Cytolysin, termed as Gigantoxin-4, was isolated from the sea anemone Stichodac-
tyla gigantea and found to be highly homologous with Cytolysin-3 (HMg III) from Heter-
actis  magnifica,  RTX-A  from  Radianthus  macrodactylus,  and  Sticholysin-1  (St  I)  and 
Sticholysin-2 (St II) from Stichodactyla helianthus (homology 82%, 86%, 82% and 86% re-
spectively).  Its  20  N-terminal  residues  were  identified  and  the  full-length  cDNA  se-
quence  was  obtained  by  reverse  transcription-polymerase  chain  reaction  (RT-PCR). 
Multiple sequence alignments with other Cytolysins of the actinoporin family  clearly 
indicated that Gigantoxin-4 belongs to this protein family. SDS-PAGE electrophoresis 
showed that this new actinoporin had a molecular mass of about 19 kDa, and possessed a 
high hemolytic activity to human erythrocytes (HA50= 40 ng/ml), which was inhibited by 
pre-incubation  with  sphingomyelin  (SM)  or  SM-cholesterol  mixtures.  Our  in vivo  ex-
periments showed that Gigantoxin-4 had wide toxicity to the rat cardiovascular system 
and the respiratory system. A concentration of 30μg/kg Gigantoxin-4, i.v. produced a 
positive inotropic effect on the rat heart although final cardiovascular failure was inevi-
table, and 60μg/kg Gigantoxin-4 caused respiratory arrest rapidly resulting in rat death. 
HE staining indicated pathological changes in various organs and tissues after i.v. ad-
ministration of Gigantoxin-4. 
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INTRODUCTION 
Sea anemones are rich sources of biologically ac-
tive peptides and proteins, including neurotoxins [1], 
enzymes [2, 3] and cytolysins [4, 5]. Actinoporins are 
20 kDa cytolytic proteins that interact with sphingo-
myelin in cellular and artificial membranes found in 
sea anemone [6]. Equinatoxins from Actinia equina [7] 
and  sticholysins  from  Stichodactyla helianthus  [8]  are 
two of the most studied representatives of the actin-
oporin  family,  a  class  of  eukaryotic  pore-forming 
toxins (PFTs) found in sea anemones. The molecular 
mechanism of pore formation has been considered a 
multi-step process that involves recognition of mem-
brane sphingomyelin, firm binding to the membrane 
accompanied by the transfer of the N-terminal region 
to the lipid–water interface and finally pore formation 
after  oligomerisation  of  3-4  monomers  with  accom-
panying  pore  formation  [6,  9].  Cytolysin-1  and  Cy-
tolysin-2  (HMg  I  and  II)  [10],  and  Cytolysin-3  [11] 
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belong  to  the  family  of  Cytolysins  from  the  sea 
anemone  H. magnifica.  Recent  research  in  52  cloned 
HMg gene sequences showed that HMgs are encoded 
by  a  multigene  family  whose  members  are  highly 
homologous  to  each  other  [12].  Some  sea  anemone 
toxins,  including  cytolysins  and  neurotoxins,  have 
been  investigated  for  their  putative  cardiotonic  ac-
tions [13] and anticancer effects [14]. 
An  epidermal  growth  factor  (EGF)-like  toxin 
(gigantoxin  I)  and  two  sodium  channel  toxins  (gi-
gantoxins II and III), previously isolated from the sea 
anemone Stichodactyla gigantea[15], Gigantoxin I is the 
first example of EGF-like toxins of natural origin[16]. 
The present work reported the isolation and charac-
terization of a new actinoporin toxin from S. gigantea, 
whose cDNA sequences were confirmed by RT-PCR. 
In addition, we also tried to clarify interactions be-
tween lipid vesicles and Gigantoxin-4. The toxic effect 
of Gigantoxin-4 in vivo was also studied by directly 
injecting  the  Gigantoxin-4  in  anaesthetized  Spra-
gue-Dawley (SD) rats. 
MATERIALS AND METHODS 
Animals and venom collection 
Specimens of S. gigantea were collected from the 
South China Sea. The tentacles of live animals were 
cut into pieces and then thoroughly freeze dried. A 
total volume of 20 ml cold deionized H2O was added 
to 5 g tentacle pieces. The suspension was homoge-
nized with a blender for 15 min at 4°C and centrifuged 
for 20 min at 27,000 ×g at 4°C. The supernatant was 
stored for future use. Part of the sample was quickly 
frozen in liquid nitrogen for total RNA preparation 
and then stored at -75°C. 
Purification of Gigantoxin-4 from Stichodactyla 
gigantea 
One  milliliter  reconstituted  crude  extract  was 
purified  with  a  filter  (pore  diameter  0.45  μm).  The 
filtrate  was  applied  to  a  Hitrap  Capto  S  cation  ex-
change column (0.7×2.5 cm, GE, USA) connected to an 
ÄKTA purifier 100 System (GE Healthcare, Sweden). 
The column for chromatography was eluted with a 
step NaCl gradient, where elution buffer A was 50mM 
ammonium acetate (pH 5.6), and elution buffer B was 
1 M NaCl, 50 mM ammonium acetate (pH 5.6). The 
elution started with 0% buffer B, with its proportion 
raised to 11%, 21%, 30% and 100% after every 5 ml of 
elution volume at a flow rate of 1 ml/min. The eluted 
peak was monitored simultaneously at a wavelength 
of 215 and 280 nm. Peaks showing the high hemolytic 
activity were collected and lyophilized. 
The hemolytic fractions were further purified by 
gel  chromatography.  A  total  of  2  ml  concentrated 
protein solution was applied to a HiLoad 16/60 Su-
perdex 75 prep grade size-exclusion column (60 × 1.6 
cm, GE, USA). The column for chromatography was 
equilibrated  and  eluted  with  150  mM  ammonium 
acetate (pH 5.1) at a flow rate of 1 ml/min. Eluted 
peaks  were  monitored  simultaneously  at  a  wave-
length of 215 and 280 nm. Peaks showing the  high 
hemolytic activity were collected and lyophilized. 
The  protein  concentration  of  the  purified  Gi-
gantoxin-4  was  determined  by  the  ultraviolet  spec-
trophotometric method. The separation of each frac-
tion was monitored by SDS-PAGE.  
Mass spectrometry analysis and N-terminal 
amino acid sequence determination 
The  Nano-LC  MS/MS  experiment  was  per-
formed in the proteomics  laboratory  of Fudan Uni-
versity School of Medicine (Shanghai, China) using an 
HPLC system composed of two LC-20AD nano-flow 
LC  pumps,  an  SIL-20  AC  auto-sampler  and  an 
LC-20AB micro-flow LC pump (all Shimadzu, Tokyo, 
Japan) connected to an LTQ-Orbitrap mass spectrom-
eter  (ThermoFisher,  San  Jose,  CA).  MGF  files  were 
analyzed  using  Mascot  2.2.07  against  the  NCBI  nr 
database 2010 Sep release. 
The  N-terminal  amino  acid  sequence  analysis 
was  performed  as  described  by  Bellomio  et  al  [17]. 
SDS-PAGE  protein  bands  (about  19  kDa)  corre-
sponding to the hemolytic peaks were transferred to a 
polyvinylidene ﬂuoride (PVDF) membrane, and were 
then excised to have their 20 N-terminal residues se-
quenced by the Edman degradation method with a 
PROCISETM492cLC (ABI, USA). 
Cloning and determination of the sequence 
Total RNA was obtained from a single specimen 
of  S.  gigantea  following  the  manufacturer’s  instruc-
tions of RNAiso Plus (TaKaRa, Japan) and was used 
as  a  template  for  synthesis  and  ampliﬁcation  of 
cDNAs  coding  for  actinoporins  using  a  RevertAid 
First  Strand  cDNA  Synthesis  Kit  (Fermentas,  USA) 
following  the  manufacturer’s  instructions.  Peak  2’ 
showed  a  high  similarity  and  identity  with  Cytoly-
sin-3 using BLASTP according to mass spectrometry 
and N-terminal amino acid sequencing results. Thus, 
the complete cds of gIII(GenBank: AF170706.1) were 
used  to  design  primers.  The  forward  primer 
(CGTCTCATCGTCTTATTT) and the reverse primer 
(TGTCTTCTTATTAGCGTG)  were  used  in  RT-PCR. 
cDNAs with a size about 630 base pairs were purified 
from PCR products and sent to Invitrogen Corpora-




Hemolytic activity (HA) and inhibition of the 
hemolytic activity of Gigantoxin-4 
The hemolytic activity was assayed as described 
by de Oliveira et al [18]. An erythrocyte suspension 
was prepared using fresh human red blood cells and 
washed  with  phosphate-buffered  saline  (PBS)  until 
the supernatant was clear. Erythrocytes were resus-
pended in the same buffer to a final erythrocyte con-
centration  of  0.5%.  The  erythrocyte  suspension  was 
incubated  with  various  concentrations  of  Gigantox-
in-4 at 37°C for 30 min and then centrifuged at 3,000 g 
for 5 min to precipitate both intact erythrocytes and 
ghosts. Optical density of the supernatant was meas-
ured using a microplate reader (Bio-Rad, USA) at 420 
nm. Background or total cell hemolysis was evaluated 
by incubation of erythrocytes with PBS or 0.5% Triton 
X-100 in PBS. The percentage of hemolysis was cal-
culated as follows: %hemolysis = [(Abssample −AbsPBS) 
/ (AbsTriton −AbsPBS)] ×100. 
In another experiment, the erythrocyte suspen-
sion was incubated with Gigantoxin-4 (0.08 μg/ml) at 
37°C for 10, 20, 30, 40, 50 and 60 min, respectively. The 
hemolytic activity was assayed by the same method 
and observed with a laser scanning confocal micro-
scope (LeicaCTS SP2). 
Small unilamellar vesicles (SUV) were prepared 
as described [19] and used for the experiment on in-
hibition of the hemolytic activity. SUV of egg phos-
phatidylchoine  (PC),  sphingomyelin  (SM),  SM:  cho-
lesterol (Cho) 1:1, SM: PC 1:1 and SM: Cho: PC 1:1:1 
(molar ratios) were incubated with Gigantoxin-4 (0.1 
μg/ml to promote 100% hemolysis) at different lipid 
concentrations, and the remaining HA was assayed as 
previously described. 
Physicochemical factors influence on HA of Gi-
gantoxin-4 
Gigantoxin-4 (0.1 μg/ml) was incubated for 20 
min at temperatures from 20°C to 80°C, and preserved 
at 25°C for 6, 12, 24 and 36 h to assess the influence of 
preservation time on Gigantoxin-4 toxicity. In another 
experiment, Gigantoxin-4 was freeze-thawed for 5, 10 
and  20  cycles.  After  completing  these  experiments, 
toxins were submitted for hemolytic assay. 
Permeabilization of LUV 
Large unilamellar vesicles (LUVs) were prepared 
as previously described [20]. The permeabilizing ef-
fect  of  Gigantoxin-4  on  LUV  was  determined  by 
measuring the fluorescence of released calcein with a 
fluorescence  microplate  reader  (Biotek  synergy2, 
USA) with excitation and emission wavelengths set at 
485  nm  and  535  nm  [21].  Gigantoxin-4,  at  various 
concentrations in a vesicle buffer, was dispensed in a 
multiwell  microplate,  and  then  in  an  appropriate 
amount of calcein-loaded LUV (0.1 M final concentra-
tion),  the  volume  totaling  200  μl.  After  mixing  the 
vesicles and the toxin, fluorescence intensity increased 
due to the release of calcein. Maximum release was 
always obtained by adding 0.5% Triton X-100 (final 
concentration)  and  provided  the  fluorescence  value 
Fmax. The percentage of release R (%) was calculated as 
follows: R (%) = (Fsample-Fin)/( Fmax -Fin) ×100, where Fin 
and  Fsample  represent  the  initial  and  the  sample 
(steady-state) value of fluorescence before and after 
toxin addition. 
General surgical procedures and in vivo hemo-
dynamics 
Male SD rats weighing 280-330 g were supplied 
by the Laboratory Animal Center of the Second Mili-
tary Medical University in Shanghai, China. All ani-
mal experiments were approved by the Ethics Com-
mittee of said university. The general surgical proce-
dures were similar to those described previously [22].  
Male SD rats were anaesthetized with pentobar-
bital  sodium  (60  mg/kg  i.p.)  and  the  trachea  was 
cannulated  to  facilitate  mechanical  ventilation.  A 
catheter was inserted into the left femoral artery for 
recording blood pressure (BP) by connecting it to a BP 
transducer. Another catheter was inserted into the left 
femoral  vein  for  intravenous  administration  of  Gi-
gantoxin-4.  The  mean  arterial  pressure  (MAP)  was 
derived from the BP pulse. Left ventricular pressure 
(LVP) and heart rate (HR) were measured through a 
Millar BP catheter (SPR-524, Millar Instruments Inc, 
US), which was introduced through the right carotid 
artery into the left ventricular cavity and connected to 
another  BP  transducer.  The  first  derivative  of  LVP 
(dP/dtmax, dP/dtmin,), an index of cardiac systolic and 
diastolic  function,  was  derived  from  differentiating 
the signal of LVP using an electronic differentiator. A 
Powerlab/8SP ADInstruments System (Pty.Ltd. Cas-
tel Hill, Australia) was used to monitor and record 
changes of dP/dtmax, dP/dtmin, MAP and HR. 
Analysis of activities of liver and heart dam-
age-related enzymes 
At  30  and  60  min  of  Gigantoxin-4  injection 
(30μg/kg i.v.), blood samples were collected in hepa-
rinized  tubes.  Liver  and  heart  damage-related  en-
zymes  including  alanine  aminotransferase  (ALT), 
aspartate  aminotransferase  (AST),  lactate  dehydro-
genase  (LDH),  creatine  kinase  (CK)  and  MB  isoen-
zyme  of  creatine  kinase  (CK-MB)  were  determined 
using an automatic biochemical analyzer (Hitachi 917, 





After  treatment  with  Gigantoxin-4  (30  μg  /kg 
i.v.) for 60 min, the heart, lung, liver and kidney were 
collected from SD rats, fixed in 10% paraffin formal-
dehyde,  sliced  to  6-mm  sections,  hematoxylin  and 
eosin (HE) stained, and then examined under a light 
microscope (100× magnification). 
Statistical analysis 
Values were expressed as mean ±SD. Statistical 
analysis was performed either by Student’s t test for 
paired data or unpaired data. Differences were con-
sidered to be significant at *p < 0.05, **p <0.01. 
RESULTS 
Purification of Gigantoxin-4 
Cation-exchange  on  Capto  S  column  of  water 
solution of the crude extract of S. gigantea presented 
four  peaks,  of  which  peak  1  and  2  were  hemolytic 
(Fig. 1A). Then peak 1 was pooled, lyophilized and 
applied onto a Superdex 75 column and peak 1’ with 
hemolytic activity was obtained (Fig. 1B). In the same 
way, peak 2 was applied onto the Superdex 75 column 
and peak 2’ with hemolytic activity was obtained (Fig. 
1C). SDS-PAGE electrophoresis showed that peak 1’ 
and 2’ had an apparent molecular mass of about 19 
kDa (Fig. 1E).  
Mass spectrometry and N-terminal amino acid 
sequencing 
The N-terminal amino acid sequences of the pu-
rified  peak  1’  and  2’  were  both  determined  as 
SASAVAGTIIEGASLTFQILDKV (amino acids from 1 
to 22). The Nano-LC MS/MS experiment revealed two 
internal  peptide  sequences:  SGTTDVILP 
EFVPNQKALL YSGR; G IMTSAGEAK (Fig. 2A). The 
sequences of N-terminal amino acid and peptide as 
assayed by MS/MS were almost identical to that of 
Cytolysin-3 reported by Wang et al [12]. We named 
peaks 2’ as Gigantoxin-4, all the researches below fo-
cused on peak 2’. 
 
 
Fig. 1. Purification of Gigantoxin-4. (A) Cation-exchange chromatography on Hitrap Capto S (0.7 × 2.5 cm, GE, USA) 
using an ÄKTA purifier 100 System (GE, USA). 1 ml crude extract was applied to the column, which was eluted with a 
gradient of 11%, 21%, 30% and 100% NaCl (1.0 M) in 50 mM ammonium acetate buffer (pH 5.6) at a flow rate of 1 
ml/min. Peak 1 and 2 show the high hemolytic activity collected. (B) Gel-filtration chromatography. 2 ml of the 
concentrated peak 1 protein solution was applied to the Superdex
 75 column (1.6 × 60 cm, GE, USA), which was eluted 
with 150 mM ammonium acetate buffer (pH 5.1) with a flow rate of 1 ml/min. (C) Gel-filtration chromatography. A 
concentrated sample of peak 2 was applied to the Superdex
 75 column. (D) SDS-PAGE analysis of mucus exudates (V1) 
and crude extract (V2) from S. gigantea. (E) SDS-PAGE analysis of fractions collected after Gel-filtration chroma-
tography. (M) Marker, (1’) peak 1’, (2’) peak 2’. 







Fig. 2. cDNA sequence and multiple sequence alignment of Gigantoxin-4. (A) cDNA sequence of Gigantoxin-4. The 
corresponding amino acid sequence is shown in boldface. The sequences of N-terminal amino acid and peptide as 
assayed by MS/MS are underlined. (B) Multiple sequence alignment of actinoporins. Alignment was performed with 
CLUSTLW in the Uniprot Knowledgebase. Identical residues are shown on a gray background. 
 
 





cDNA cloning and multiple sequence alignment 
of Gigantoxin-4 
cDNA of Gigantoxin-4 revealed an open reading 
frame of 195 amino acids with the ATC stop coding at 
position  588  (Fig.  2A).  The  deduced  protein  had  a 
predicted  signal  peptide  composed  of  the  first  17 
amino acids. A molecular mass of 19 kDa was pre-
dicted  for  the  putative  mature  protein,  which 
matched our SDS-PAGE results. A sequence similarity 
search in the GenBank database using BLASTN and 
BLASTP programs indicated that Gigantoxin-4 should 
belong to the actinoporin family. When aligned with 
the known actinoporins, the deduced complete amino 
acid sequences of Gigantoxin-4 showed a high simi-
larity and identity with Cytolysin-3 from H. magnifica 
(82%),  RTX-A  from  R.  macrodactylus  (86%), 
Sticholysin-1  (82%)  and  Sticholysin-2  (86%)  from  S. 
helianthus, Or-G from Oulactis orientalis orientalis (72%) 
[23], and Equinatoxin-2 from A. equina (65%)(Fig. 2B).  
In vitro activity, inhibition and influencing fac-
tors of Gigantoxin-4-induced hemolysis 
The  concentration  of  Gigantoxin-4  that  lysed 
50% erythrocytes was 45 ng/ml (Fig. 4A), which was 
similar to that of St I and St II (HA50 ≈30-45 ng /ml) 
obtained  by  Lanio  et  al  [8].  Gigantoxin-4  induced 
100% hemolysis at the concentration of 80 ng/ml.  
After Gigantoxin-4 (80 ng/ml) treatment, eryth-
rocytes  showed  a  series  of  changes  with  a  gradual 
emergence of deformation and ultimate death within 
40 min (Fig. 3A). Hemolytic effects of Gigantoxin-4 on 
erythrocytes were observed under the prescribed vi-
sion with a laser scanning confocal microscop (Fig. 3B 
- Fig. 3E). 
The hemolytic activity of Gigantoxin-4 was in-
hibited  significantly  by  preincubation  with  SUV 
composed  of  SM/Cho  or  SM/Cho/PC,  and  almost 
completely bereaved at a low concentration of 3μg/ml 
(Fig. 4B), while no significant inhibitory effect of PC 
lipids on the hemolytic activity of Gigantoxin-4 was 
observed even at a high concentration of 1mg/ml. The 
hemolytic  activity  of  Gigantoxin-4  was  also  almost 
entirely inhibited by SUV composed of SM/PC at a 
concentration  of  0.1  mg/ml,  but  SUV  composed  of 
pure SM only caused a 20% decrease in the hemolytic 





Fig. 3. Hemolytic activity of Gigantoxin-4. (A) Time-dependent changes in vitro of Gigantoxin-4-induced hemolysis. 
The series of changes (indicated by the arrow) with a gradual emergence of deformation and ultimate death of 
erythrocytes were observed with laser scanning confocal microscop (1000× magnification) after (B) 10 min, (C) 20 
min, (D) 30 min and (E) 40 min. Scale bar corresponds to 10 µm. 





Fig. 4. In vitro activity, inhibition and influencing factors of Gigantoxin-4-induced hemolysis. (A) Concentration 
dependence. The concentration of Gigantoxin-4 to lyse 50% erythrocytes is 45ng/ml. (B) Inhibition of Gigantox-
in-4-induced hemolysis by SUV. Gigantoxin-4 (0.1μg/ml) was preincubated (30 min at 37°C) with an appropriate 
amount of SUV. The mixture was diluted with erythrocyte buffer to the desired vesicle concentration and incubated 
for 30 min at 37°C. Hemolysis was monitored at 420 nm. Each result is the mean value of three experiments. (C) 
Influence of temperature on the hemolytic activity of Gigantoxin-4. (D) Influence of standing time on the hemolytic 
activity of Gigantoxin-4 at room temperature. (E) Influence of freeze-thaw cycles on the hemolytic activity of Gi-
gantoxin-4. All data are expressed as mean ± SD (n = 5). 
 
Temperature was a very important factor influ-
encing  the  stability  of  Gigantoxin-4  in  vitro.  After 
20-min incubation at 20 °C, 40 °C, 50 °C and 60 °C, the 
hemolytic  ability  of  Gigantoxin-4  gradually  de-
creased. When it was heated to 70 °C and 80 °C, the 
hemolytic activity of Gigantoxin-4 was almost com-
pletely lost (Fig. 4C). Repeated freeze-thaw cycles also 
inactivated Gigantoxin-4. Although 25 freeze-drying 
cycles  caused  a  25%  loss  of  the  hemolytic  activity, 
there was still 40% hemolytic activity remaining after 
40 freeze-drying cycles (Fig. 4D). In addition, the he-
molytic activity of Gigantoxin-4 gradually decreased 
in response to prolonged standing time at room tem-
perature, and 24 h later the protein was almost com-
pletely degraded (Fig. 4E). We also found that there 
were no obvious difference if adding protease inhibi-
tors (10 mM PMSF and EDTA)or not (data was not 
shown).  Therefore,  we  got  the  conclusion  that  the 
activity  loss  of  Gigantoxin-4  is  not  due  to  the  con-
tamination with proteases but the high temperature or 
solution condition resulting in the protein denatura-
tion. 
Permeabilizing effect on LUV 
Our result showed that a  calcein leak  was de-
tectable when LUV composed of SM: Cho: PC (1:1:1 
molar ratio) was used. The percentage of calcein re-
lease  increased  with  the  Gigantoxin-4  concentration 
increasing. However, almost no calcein was detectable 
when LUV composed of pure PC was used (Fig. 5). 
 
 
Fig. 5. Permeabilization of LUV. It was determined by 
measuring the fluorescence of released calcein with a 
fluorescence microplate reader (Biotek synergy2, USA). 
The  excitation  wavelength  was  485  nm  and  emission 
wavelength was set at 535 nm. 200 μl Gigantoxin-4 of 
different concentrations dissolved in vesicle buffer (140 
mM NaCl, 20 mM Tris, 1 mM EDTA, pH 7.5) was added 
into each well, and calcein release was monitored. Each 




Dose and time dependent changes in vivo left 
ventricle (LV) function induced by Gigantoxin-4 
in SD rats  
A  total  of  10  rats  were  used  to  determine 
whether injection of Gigantoxin-4 (30 μg/kg and 60 
μg/kg,  i.v.)  influenced  LV  function.  Gigantoxin-4 
administration  (60  μg/kg,  i.v.)  evoked  a  transient 
hypotensive and bradycardic effect when pressor re-
sponse was observed. However, fatal cardiovascular 
collapse ensued within 3 min, causing rat death (Fig. 
6). A mild and transient decline in BP was also ob-
served  at  a  low  dose  of  30μg/kg,  followed  by  a 
gradual increase in the following 20 min (Fig. 6). In 
addition,  dP/dt,  MBP  and  HR  kept  increasing  for 
about  25  min  and  then  gradually  decreased  within 
30-60 min (data not shown). Interestingly, decreased 
hemodynamics induced by Gigantoxin-4 (60 μg/kg, 
i.v.) could be gradually restored and even increased 
significantly  when  the  rat  was  connected  to  the 
breathing machine on time, extending the life span of 
the rat by tens of minutes to hours. However, the rat 
died immediately when the breathing machine was 
withdrawn.  
Effects of Gigantoxin-4 on liver and heart dam-
age-related enzymes  
As shown in Fig. 7A, the liver damage-related 
enzymes ALT and AST were significantly increased 
60  min  after  Gigantoxin-4  injection  (30  μg/kg  i.v.) 
compared with those of the control group. In addi-
tion,  LDH,  CK  and  CK-MB  were  significantly  in-
creased  after  30-min  Gigantoxin-4  administration 
(Fig. 7B).  
 
 
Fig. 7. Effects of Gigantoxin-4 at 30 μg/kg i.v. on ALT, 
AST, LDH, CK and CK-MB. All the results were expressed 
as  mean  ±  SD  (n=6).  Significant  difference  from  the 
respective  preinjection  value  was  expressed  as  *p  < 
0.05, **p <0.01.  
 
Fig. 6. Dose and time-dependent changes in vivo LV function induced by Gigantoxin-4 (30 μg/kg and 60 μg/kg, 
i.v.) in SD rats. ±dP/dt = slope of LVP, HR= heart rate, MAP= mean femoral arterial pressure. Control data were 
preinjection value (0 min), and data are mean ±SD (n=6). Significant difference from the respective preinjection 






Damage to important tissues of the rats (Fig. 8) 
was also evaluated 60 min after Gigantoxin-4 (30 μg 
/kg  i.v.)  administration.  HE-staining  showed  acute 
pulmonary  congestion,  interstitial  edema,  alveolar 
wall thickening and slight infiltration of tissue fluid 
into alveolar space in the lung (Fig. 8E). The myocar-
dial tissue was congested, with sporadic necrosis (Fig. 
8F).  Acute  congestion  and  multiple  focal  necroses 
were observed in the liver (Fig. 8G). Sporadic hem-
orrhage and hyaline casts were observed in the kid-
ney (Fig. 8H). These toxic effects of Gigantoxin-4 on 
organs were similar to those observed in tentacle-only 





Fig. 8. Histopathological analysis of the lung, heart, liver and kidney of SD rats 60 min after Gigantoxin-4 ad-
ministration (30 μg/kg i.v.) (100× magnification). (A) Normal pulmonary tissue. (B) Normal heart tissue. (C) Normal 
liver tissue. (D) Normal kidney tissue. (E) Acute congestion was present in the lung (indicated by the arrow). (F) 
Sporadic necrosis was present in the heart. (indicated by the arrow). (G) Multiple focal necroses were present in the 




The  present  study  characterized  the  structure 
and bioactivities of a new cytolysin isolated from the 
sea anemone Stichodactyla gigantea, termed as Gigan-
toxin-4, identified its 20 N-terminal residues, and ob-
tained  the  full-length  cDNA  sequence.  A  sequence 
similarity  search  in  the  GenBank  indicated  that  Gi-
gantoxin-4  should  belong  to  the  actinoporin  family 
due  to  the  high  sequence  similarity  to  Cytolysin-3 
(82%),  Sticholysin-1  (82%),  Sticholysin-2  (86%)  and 
RTX-A (86%). 
It  was  reported  that  actinoporin  could  make 
pores in cellular, lipid or artificial membranes, which 
could  be  formed  efficiently,  especially  when  cell 
membranes  contained  sphingomyelin  [25-28].  Pore 
formation on the cell surface may increase membrane 
permeability or cause leakage of cell contents, leading 
to cell death. Our work confirmed that Gigantoxin-4 
induced  lysis  of  erythrocytes  (HA50=40  ng/ml)  and 
leakage  of  calcein  wrapped  in  LUV,  indicating  that 
the target of Gigantoxin-4 was the cell membrane. We 
also found that the various components of the lipid 
membrane  showed  different  potential  interactions 
with  Gigantoxin-4.  SUV  composed  of  pure  PC 
showed  no  significant  effect  on  hemolytic  activity. 
The hemolytic activity  of  Gigantoxin-4 could be  in-
hibited more rapidly and significantly by SUV com-
posed of SM/Cho/PC as compared with SUV com-
posed  of  pure  SM.  Similar  data  was  obtained  by  a 




calcein was observed when LUV composed of pure 
PC was used. However, a calcein leak was detectable 
when LUV composed of SM: Cho: PC was used, in-
dicating  that  Cytosin-4  had  a  high  affinity  to  LUV 
composed of SM and Cho. Although our results are 
not  completely  consistent  with  the  reports  of  other 
researchers,  one  point  is  identical:  when  SM  is  one 
component of the cell membrane, it will be affected by 
the cytolytic effect of actinoporins. 
Another important finding of the present study 
is that administration of a high concentration of Gi-
gantoxin-4 (60 μg/kg, i.v.) caused respiratory arrest, 
which might be the primary factor causing death of 
the rat. Histological analysis also confirmed that the 
lung was the most seriously injured organ after Gi-
gantoxin-4 administration. The lung has been consid-
ered the predominant site of marginated neutrophil 
pool  [29].  The  hemolysis  induced  by  Gigantoxin-4 
caused the leakage of cell contents, thus stimulating 
activation  of  neutrophils.  Activated  neutrophils  ap-
pear to play a central role in the development of acute 
lung injury in most cases [30]. Therefore, our study 
gives an important reference for the design of thera-
peutic strategies of sea anemone stings. By compari-
son, rats can live tens of minutes to hours after in-
jecting  low-dose  Gigantoxin-4(30  μg/kg,  i.v.),  alt-
hough final cardiovascular failure was inevitable. The 
hemolysis induced by Gigantoxin-4 also maybe cause 
hyperkalemia, the most common cause of heart failure 
due to the massive hemolysis in the blood of the rat. 
Biochemical  analysis  showed  that  plasma  levels  of 
liver and heart related enzymes were increased sig-
nificantly,  indicating  that  the  toxic  effect  of  Gigan-
toxin-4 was  systemic. Similar results were found in 
EqT II from A. equina, causing a drop in the perfusion 
rate, decrease in LVP, arrhythmia and increased LDH 
release [13]. Our further research will focus on how to 
block or mitigate the damage to cells and organs in-
duced by Gigantoxin-4. 
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